Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer

od Bordi, Paola, Del Re, Marzia, Danesi, Romano, Tiseo, Marcello
izdano v Transl Lung Cancer Res (2015)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

od Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
Izdano 2014

Clinical pharmacology of intravitreal anti-VEGF drugs

od Fogli, Stefano, Del Re, Marzia, Rofi, Eleonora, Posarelli, Chiara, Figus, Michele, Danesi, Romano
izdano v Eye (Lond) (2018)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins

od Arrigoni, Elena, Del Re, Marzia, Fidilio, Leonardo, Fogli, Stefano, Danesi, Romano, Di Paolo, Antonello
izdano v Int J Mol Sci (2017)

Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment

od Del Re, Marzia, Latiano, Tiziana, Fidilio, Leonardo, Restante, Giuliana, Morelli, Franco, Maiello, Evaristo, Danesi, Romano
izdano v EPMA J (2017)

Radiomics and liquid biopsy in oncology: the holons of systems medicine

od Neri, Emanuele, Del Re, Marzia, Paiar, Fabiola, Erba, Paola, Cocuzza, Paola, Regge, Daniele, Danesi, Romano
izdano v Insights Imaging (2018)

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

od Ravegnini, Gloria, Del Re, Marzia, Grolla, Ambra A., van Schaik, Ron H. N., Angelini, Sabrina
izdano v Front Pharmacol (2020)

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

od Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
izdano v EPMA J (2015)

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

od Banna, Giuseppe Luigi, Cantale, Ornella, Bersanelli, Melissa, Del Re, Marzia, Friedlaender, Alex, Cortellini, Alessio, Addeo, Alfredo
izdano v Oncol Rev (2020)

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

od Del Re, Marzia, Di Paolo, Antonello, van Schaik, Ron H., Bocci, Guido, Simi, Paolo, Falcone, Alfredo, Danesi, Romano
Izdano 2010

Genetic variation: effect on prostate cancer

od Sissung, Tristan M., Price, Douglas K., Del Re, Marzia, Ley, Ariel M., Giovannetti, Elisa, Figg, William D., Danesi, Romano
izdano v Biochim Biophys Acta (2014)

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

od Del Re, Marzia, Rofi, Eleonora, Cappelli, Carla, Puppo, Gianfranco, Crucitta, Stefania, Valeggi, Simona, Chella, Antonio, Danesi, Romano, Petrini, Iacopo
izdano v BMC Cancer (2019)

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

od Del Re, Marzia, Rofi, Eleonora, Restante, Giuliana, Crucitta, Stefania, Arrigoni, Elena, Fogli, Stefano, Di Maio, Massimo, Petrini, Iacopo, Danesi, Romano
izdano v Oncotarget (2017)

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

od Martignano, Filippo, Munagala, Uday, Crucitta, Stefania, Mingrino, Alessandra, Semeraro, Roberto, Del Re, Marzia, Petrini, Iacopo, Magi, Alberto, Conticello, Silvestro G.
izdano v Mol Cancer (2021)

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy

od Mulder, Tessa A. M., de With, Mirjam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.
izdano v Cancers (Basel) (2021)

Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment

od Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello
izdano v Stem Cells Transl Med (2018)

erbB in NSCLC as a molecular target: current evidences and future directions

od Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Fogli, Stefano, Passaro, Antonio, Crucitta, Stefania, Attili, Ilaria, De Marinis, Filippo, Chella, Antonio, Danesi, Romano
izdano v ESMO Open (2020)

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

od Del Re, Marzia, Vivaldi, Caterina, Rofi, Eleonora, Vasile, Enrico, Miccoli, Mario, Caparello, Chiara, d’Arienzo, Paolo Davide, Fornaro, Lorenzo, Falcone, Alfredo, Danesi, Romano
izdano v Sci Rep (2017)

Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring

od Pasqualetti, Francesco, Restante, Giuliana, Gonnelli, Alessandra, Rofi, Eleonora, Molinari, Alessandro, Crucitta, Stefania, Paiar, Fabiola, Rudà, Roberta, Danesi, Romano, Soffietti, Riccardo, Del Re, Marzia
izdano v Neuro Oncol (2019)

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Trans...

od Bruno, Rossella, Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Alì, Greta, Crucitta, Stefania, Proietti, Agnese, Valleggi, Simona, Chella, Antonio, Danesi, Romano, Fontanini, Gabriella
izdano v Front Oncol (2021)